PT  - JOURNAL ARTICLE
AU  - C. Thompson
AU  - N. Grayson
AU  - R.S. Paton
AU  - J Lourenco
AU  - BS Penman
AU  - L. Lee
AU  - V. Odon
AU  - J. Mongkolsapaya
AU  - S. Chinnakannan
AU  - W. Dejnirattisai
AU  - M. Edmans
AU  - A. Fyfe
AU  - C. Imlach
AU  - K. Kooblall
AU  - N. Lim
AU  - C. Liu
AU  - C. Lopez-Camacho
AU  - C. McInally
AU  - N. Ramamurthy
AU  - J. Ratcliff
AU  - P. Supasa
AU  - B. Wang
AU  - A. Mentzer
AU  - M. Turner
AU  - M.G. Semple
AU  - JK Baillie
AU  - ISARIC4C Investigators
AU  - H. Harvala
AU  - G.R. Screaton
AU  - N. Temperton
AU  - P. Klenerman
AU  - L.M. Jarvis
AU  - S. Gupta
AU  - P. Simmonds
TI  - Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors – a pilot study of the value of serology to determine population exposure
AID  - 10.1101/2020.04.13.20060467
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.13.20060467
4099  - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20060467.short
4100  - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20060467.full
AB  - Background The extent of spread of SARS coronavirus 2 (SARS-CoV-2) in the UK and elsewhere is unknown because typically only symptomatic individuals are diagnosed. We performed a serological study of recent blood donors in Scotland to detect antibodies to SARS-CoV-2 as a marker of past infection.Methods A pseudotyped SARS-CoV-2 virus microneutralisation assay was used to detect neutralising antibodies to SARS-CoV-2. The study group comprised samples from 1000 blood donors collected in Scotland during March, 2020. Controls were collected from 100 donors in Scotland during 2019.Findings All samples collected on the 17th March, 2020 (n=500) were negative in the pseudotyped SARS-CoV-2 virus microneutralisation assay. Neutralising antibodies were detected in 5 of the 500 samples collected 21st – 23rd March; one further sample was reactive in an anti-spike ELISA.Interpretation Although we cannot use the rise in numbers seropositive to infer the contemporary seroprevalence or the growth rate of the epidemic, we note that they are consistent with frequency of reported diagnosed infections and SARS-CoV-2-associated deaths reported in that time period in Scotland, given that seroconversion takes up to 2-3 weeks. It should also be noted that blood donors are not representative of the general population; in particular, those with a history of recent respiratory infections are deferred. Finally, it is unknown what proportion of infected individuals seroconvert and become reactive in the assays used. Serial follow up studies are needed to track infection and seroconversion in this and other similar populations However, these data indicate that sero-surveys of blood banks can serve as a useful tool for tracking the emergence and progression of an epidemic like the current SARS-CoV-2 outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institute for Health Research Biomedical Recipient: Gavin Screaton Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science Award Number: 2018-I2M-2-002 Recipient: Gavin Screaton Wellcome Trust Award Number: WT103767MA Recipient: Peter Simmonds, B.M., PhD, FRCPath Wellcome Trust Award Number: 095541/A/11/Z Recipient: Gavin ScreatonAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data obtained in the study is available from the authors upon request